Sunshine Biopharma Inc.
SBFM· Nasdaq
SBFMSunshine Biopharma Inc.
Filed Aug 19, 2020 · 10-Q · 50 days after period end · 0001654954-20-009340
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $15.15K | $3.03K | $0.00 | $0.00 |
| Net Income | -$907.44K | -$710.89K | -$644.31K | -$485.44K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 19, 2020 · 50 d after period end
